SBC Medical Group (NASDAQ:SBC) Releases Earnings Results

SBC Medical Group (NASDAQ:SBC) posted its quarterly earnings results on Thursday. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.02), FiscalAI reports. SBC Medical Group had a return on equity of 15.90% and a net margin of 24.09%.The company had revenue of $49.19 million for the quarter, compared to analysts’ expectations of $45.37 million.

Here are the key takeaways from SBC Medical Group’s conference call:

• Positive Sentiment: SBC reported strong second-quarter results, with revenue up 13% to $49 million, adjusted EBITDA up 32% to $20 million, and a 41% margin. Clinic locations increased to 287, visits rose 10%, and average spend per visit increased 9%.
• Positive Sentiment: Management said domestic aesthetic medicine has re-accelerated after marketing, pricing, and treatment reforms, with same-clinic revenue up 6% and first-half transaction value up 19%. It expects a more favorable competitive environment as the pace of new clinic openings slows.
• Positive Sentiment: AI is being deployed across customer service, marketing, call-center operations, site selection, and employee training, with management targeting higher clinic revenue and greater operating efficiency. Planned service-fee increases are expected to add roughly JPY 15 million annually, with most of the contribution flowing to profit.
• Positive Sentiment: The company is broadening beyond aesthetics through non-aesthetic healthcare, international expansion, and new longevity offerings. It is targeting 1,000 clinics by 2035, while pursuing asset-light expansion in Southeast Asia and further growth with OrangeTwist in the U.S.
• Negative Sentiment: A weaker Japanese yen remains a headwind because most operations are yen-denominated, while competition in Japan has recently been intense. SG&A also increased, although management attributed much of the rise to one-time costs related to the secondary offering.

SBC Medical Group Trading Down 0.3%

Shares of SBC stock traded down $0.01 on Thursday, hitting $3.19. The stock had a trading volume of 356,648 shares, compared to its average volume of 89,881. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.82 and a quick ratio of 3.78. The firm has a market capitalization of $327.23 million, a P/E ratio of 8.18 and a beta of 0.59. The company’s 50 day moving average price is $3.07 and its 200-day moving average price is $3.57. SBC Medical Group has a 1 year low of $2.78 and a 1 year high of $5.07.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Weiss Ratings cut shares of SBC Medical Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, May 22nd. Wall Street Zen upgraded SBC Medical Group to a “hold” rating in a research report on Saturday, May 9th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $8.50.

Institutional Investors Weigh In On SBC Medical Group

Large investors have recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. acquired a new position in shares of SBC Medical Group in the fourth quarter worth $49,000. Russell Investments Group Ltd. grew its stake in SBC Medical Group by 292.0% during the 4th quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company’s stock worth $51,000 after purchasing an additional 8,771 shares in the last quarter. Nuveen LLC purchased a new stake in SBC Medical Group during the 4th quarter worth about $53,000. Wells Fargo & Company MN raised its position in SBC Medical Group by 195.1% in the 4th quarter. Wells Fargo & Company MN now owns 12,626 shares of the company’s stock valued at $54,000 after purchasing an additional 8,348 shares in the last quarter. Finally, XTX Topco Ltd purchased a new position in shares of SBC Medical Group in the 2nd quarter valued at about $64,000. 60.82% of the stock is owned by hedge funds and other institutional investors.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.